Metallothionein
(MT) is made from the expression and purification of microbial fermentation
engineering. Our products is non animal origin, purity up to 95%, and without
any additives or irritating ingredients.
Metallothionein
(MT) can be used in medicine, food, health care products and cosmetics, medical
testing reagent, chemical, environmental protection, animal, agriculture, etc.
Metallothionein
(MT) is a family of cysteine-rich, low molecular weight (MW ranging from 500 to
14000 Da) proteins. They are localized to the membrane of the Golgi apparatus.
MTs have the capacity to bind both physiological (such as zinc, copper,
selenium) and xenobiotic (such as cadmium, mercury, silver, arsenic) heavy
metals through the thiol group of its cysteine residues, which represent nearly
30% of its constituent amino acid residues.
Product list
lPure protein
Product
name
Description
Package
Human
metallothionein(hMT1)
Purity:85%,
95%
Appearance:White
solid powder
Metal:Zn,
content<4%
Harmful
heavy metal content:Conform
100 mg
1000 mg
10 g
100 g
1000 g
Human metallothionein(hMT2)
Human
metallothionein(hMT3)
Human
metallothionein(Hmt4)
lFusion protein
Product
name
Description
Package
Human
metallothionein(FMT1)
Fusion
protein, purity:85%, 95%
Appearance:White
solid powder
Metal:Zn,
content<4%
Harmful
heavy metal content:Conform
100 mg
1000 mg
10 g
100 g
1000 g
Human
metallothionein(FMT2)
Human
metallothionein(FMT3)
Human
metallothionein(FMT4)
[Product
form] Freeze dry powder (soluble in water)
[Source] Escherichia
coli engineering strain
[Purity]
85%, 95%
[Preservation]-20℃
[Valid
period] 2 years
MT was
discovered in 1957 by Vallee and Margoshe from purification of a Cd-binding
protein from horse (equine) renal cortex. MTs function is not clear, but
experimental data suggest MTs may provide protection against metal toxicity, be
involved in regulation of physiological metals (Zn and Cu) and provide
protection against oxidative stress. There are four main isoforms expressed in
humans: MT1, MT2, MT3, MT4. In the human body, large quantities are synthesised
primarily in the liver and kidneys. Their production is dependent on
availability of the dietary minerals, as zinc, copper and selenium, and the
amino acids histidine and cysteine.
Function
lMetal binding
Metallothionein
has been documented to bind a wide range of metals including cadmium, zinc,
mercury, copper, arsenic, silver, etc. Metallation of MT was previously
reported to occur cooperatively but recent reports have provided strong
evidence that metal-binding occurs via a sequential, noncooperative mechanism.
The observation of partially metallated MT (that is, having some free metal
binding capacity) suggest that these species are biologically important.
Metallothioneins
likely participate in the uptake, transport, and regulation of zinc in biological
systems. Mammalian MT binds three Zn(II) ions in its beta domain and four in
the alpha domain. Cysteine is a sulfur-containing amino acid, hence the name
"-thionein". However, the participation of inorganic sulfide and
chloride ions has been proposed for some MT forms. In some MTs, mostly
bacterial, histidine participates in zinc binding. By binding and releasing
zinc, metallothioneins (MTs) may regulate zinc levels within the body. Zinc, in
turn, is a key element for the activation and binding of certain transcription
factors through its participation in the zinc finger region of the protein.
Metallothionein also carries zinc ions (signals) from one part of the cell to
another. When zinc enters a cell, it can be picked up by thionein (which thus
becomes "metallothionein") and carried to another part of the cell
where it is released to another organelle or protein. In this way the
thionein-metallothionein becomes a key component of the zinc signaling system
in cells. This system is particularly important in the brain, where zinc
signaling is prominent both between and within nerve cells. It also seems to be
important for the regulation of the tumor suppressor protein p53.
lControl of oxidative stress
Cysteine
residues from MTs can capture harmful oxidant radicals like the superoxide and
hydroxyl radicals. In this reaction, cysteine is oxidized to cystine, and the
metal ions which were bound to cysteine are liberated to the media. As
explained in the Expression and regulation section, this Zn can activate the
synthesis of more MTs. This mechanism has been proposed to be an important
mechanism in the control of the oxidative stress by MTs. The role of MTs in
oxidative stress has been confirmed by MT Knockout mutants, but some
experiments propose also a prooxidant role for MTs.